Published May 5, 2021 at 11:43 AM EDT Listen • 50:00
Anti- Asian violence and rhetoric have increased since the start of the pandemic. As part of our ongoing series on racism and equity on The Point, we look at the history of racism against those Asian descent, and what the last year has been like for Asian Americans. We also hear stories from some of our neighbors about what they experience in the age of COVID.
Guests on the program are as follows:
Paul Watanabe, Director of the Institute for Asian American Studies at UMass Boston.
Khanh Dinh, Professor of Psychology at UMASS Lowell
Research shows a promising alternative to personalized deep brain stimulation
Millions of patients suffering from neurological and mental disorders such as depression, addiction, and chronic pain are treatment-resistant. In fact, about 30% of all major depression patients do not respond at all to any medication or psychotherapy.
Simply put, many traditional forms of treatment for these disorders may have reached their limit. Where do we go from here?
Research to be published in
Nature Biomedical Engineering led by Maryam Shanechi, the Andrew and Erna Viterbi Early Career Chair in electrical and computer engineering at the USC Viterbi School of Engineering, paves the way for a promising alternative: personalized deep brain stimulation.
E-Mail
Millions of patients suffering from neurological and mental disorders such as depression, addiction, and chronic pain are treatment-resistant. In fact, about 30% of all major depression patients do not respond at all to any medication or psychotherapy. Simply put, many traditional forms of treatment for these disorders may have reached their limit. Where do we go from here?
Research to be published in
Nature Biomedical Engineering led by Maryam Shanechi, the Andrew and Erna Viterbi Early Career Chair in electrical and computer engineering at the USC Viterbi School of Engineering, paves the way for a promising alternative: personalized deep brain stimulation. The work represents a major step forward in achieving new therapies for a whole host of neurological and mental disorders.